Abstract
In 2009, gluten-free foods were not only "hot" in the marketplace, several countries, including the United States, continued efforts to define gluten-free and appropriate labeling parameters. The regulatory process illuminates how difficult regulations based on safe scientific thresholds can be for regulators, manufacturers and consumers. This article analyzes the gluten-free regulatory landscape, challenges to defining a safe gluten threshold, and how consumers might need more label information beyond the term "gluten-free." The article includes an overview of international gluten-free regulations, the Food and Drug Administration (FDA) rulemaking process, and issues for consumers.
Publication Date
1-1-2010
Journal Title
Food and Drug Law Journal
Document Type
Article
Recommended Citation
Margaret Sova McCabe, "Balancing Consumer Protection and Scientific Integrity in the Face of Uncertainty: The Example of Gluten-Free Foods," 65 FOOD & DRUG L. J. 367 (2010).
Included in
Antitrust and Trade Regulation Commons, Consumer Protection Law Commons, Food and Drug Law Commons, Marketing Law Commons, Other Immunology and Infectious Disease Commons
Additional Information
Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/24475546